IL17A and diabetes mellitus: In the present study, we observed that the synbiotic combination decreased the key cytokine IL-6 among other proinflammatory markers (IL-8, IL17a and IFNγ) after only 30 days of treatment in healthy middle-aged volunteers without any suspicion of type 2 diabetes mellitus and cardiovascular diseases.